Alfred Penfornis
-
- Diabetes Management and Research 85
- Diabetes Treatment and Management 66
- Diabetes Management and Education 13
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 13
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
- Family Practice top 1%
- Transplantation top 2%
- Surgery top 2%
- Pancreatic function and diabetes 39
- Genetics top 5%
- Diabetes and associated disorders 32
-
- Metabolism, Diabetes, and Cancer 19
- Co-authors
- Pierre‐Yves BenhamouSophie BorotG. CharpentierSylvia FrancCharles ThivoletP.Y. BenhamouÉ. EschwègeMartin Schlumberger
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Alfred Penfornis
153 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 120
- Endocrinology, Diabetes and Metabolism 2.0k
- Family Practice 175
- Transplantation 154
- Surgery 1.3k
- Genetics 679
Countries citing papers authored by Alfred Penfornis
This map shows the geographic impact of Alfred Penfornis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred Penfornis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred Penfornis more than expected).
Fields of papers citing papers by Alfred Penfornis
This network shows the impact of papers produced by Alfred Penfornis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred Penfornis. The network helps show where Alfred Penfornis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alfred Penfornis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 15 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 3 | |
| 11 | 2019 | 23 | |
| 12 | 2018 | 13 | |
| 13 | 2017 | 1 | |
| 14 | Real life effectiveness and safety of vildagliptin compared with other OADs in European type 2 diabetes mellitus patients: results from the EDGE study | 2014 | 1 |
| 15 | 2014 | 27 | |
| 16 | 2011 | 16 | |
| 17 | Health related quality of life reference values (DHP) in people with diabetes living in France - Entred study, 2001-2003. | 2009 | 3 |
| 18 | 2005 | 48 | |
| 19 | Observance médicamenteuse dans le diabète de type 2 : influence des modalités du traitement médicamenteux et conséquences sur son efficacité | 2003 | 4 |
| 20 | 2003 | 12 |
About Alfred Penfornis
Alfred Penfornis is a scholar working on Endocrinology, Diabetes and Metabolism, Transplantation and Family Practice, having authored 170 papers that have together received 3.7k indexed citations. Recurring topics across this work include Diabetes Management and Research (85 papers), Diabetes Treatment and Management (66 papers), Pancreatic function and diabetes (39 papers), Diabetes and associated disorders (32 papers), Metabolism, Diabetes, and Cancer (19 papers), Diabetes Management and Education (13 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (13 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.0k citations), Family Practice (175 citations) and Transplantation (154 citations). Alfred Penfornis has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Pierre‐Yves Benhamou, Sophie Borot, G. Charpentier, Sylvia Franc, Charles Thivolet, P.Y. Benhamou, É. Eschwège, Martin Schlumberger, Gilles Vassal and A. Fagot‐Campagna. Their work appears in journals such as The Journal of Immunology, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.